📰 Hookipa Pharma News
Page 3 - Hookipa Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Hookipa Pharma. Real-time updates on events, politics, business and more.
August 1, 2023
Hookipa Pharma Inc (NASDAQ:HOOK – Get Free Report) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 805,900 shares, a decline of 11.5% from the June 30th total of 910,600 shares. Currently, 1.2% of the company’s stock are short sold. […]
July 6, 2023
Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) CFO Reinhard Kandera purchased 12,000 shares of Hookipa Pharma stock in a transaction that occurred on Friday, June 30th. The stock was purchased at an average price of $0.88 per share, with a total value of $10,560.00. Following the transaction, the chief financial officer now owns 28,092 shares […]
July 5, 2023
Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) CFO Reinhard Kandera acquired 12,000 shares of Hookipa Pharma stock in a transaction on Friday, June 30th. The stock was purchased at an average cost of $0.88 per share, for a total transaction of $10,560.00. Following the purchase, the chief financial officer now owns 28,092 shares in the […]
July 3, 2023
Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) CFO Reinhard Kandera acquired 12,000 shares of the company’s stock in a transaction on Friday, June 30th. The stock was acquired at an average cost of $0.88 per share, with a total value of $10,560.00. Following the completion of the purchase, the chief financial officer now directly owns […]
June 30, 2023
Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 721,000 shares, an increase of 951.0% from the May 31st total of 68,600 shares. Approximately 1.1% of the shares of the company are short sold. Based on […]
June 29, 2023
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt as to the action to be taken, please seek your own financial advice from your stockbroker, solicitor, accountant or other approp...
June 22, 2023
/PRNewswire/ -- The "Global Cancer Vaccine Partnering Terms and Agreements 2010-2023" report has been added to ResearchAndMarkets.coms offering. The Global...
June 19, 2023
Hookipa Pharma (NASDAQ:HOOK – Get Rating) and Apollomics (NASDAQ:APLM – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership. Volatility & Risk Hookipa Pharma has a beta of 0.83, […]
June 14, 2023
Hookipa Pharma Inc (NASDAQ:HOOK – Get Rating) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 68,600 shares, a drop of 78.2% from the May 15th total of 314,900 shares. Based on an average daily volume of 1,100,000 shares, the days-to-cover ratio is […]
June 6, 2023
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccine Partnering Terms and Agreements 2010-2023" report has been added to ...